MYC and medulloblastoma: MEB‐Med‐8A and D283 Med display distinct characteristics of c‐myc‐amplified Non‐WNT/Non‐SHH medulloblastoma while the third analysed cell line, Daoy, shows markers of a subgroup of SHH tumours characterized by a mutation of tumoursuppressor protein 53 24, 25, 26, 27, 28, 29, 30.